Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas

References

• Mauro F R, Foa R, Cerretti R, Giannarelli D, Coluzzi S, Mandelli F, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood 2000; 95: 2786–2792
   PubMed Web of Science ®Google Scholar
• Hamblin T J. Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol 2006; 33: 230–239
   PubMed Web of Science ®Google Scholar
• Hamblin T J, Oscier D G, Young B J. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol 1986; 39: 713–716
   PubMed Web of Science ®Google Scholar
• Sallah S, Wan J Y, Hanrahan L R. Future development of lymphoproliferative disorders in patients with autoimmune haemolytic anemia. Clin Cancer Res 2001; 7: 791–794
   PubMed Web of Science ®Google Scholar
• Myint H, Copplestone J A, Orchard J, Craig V, Curtis D, Prentice A G, et al. Fludarabine-related AIHA in patients with chronic lymphocytic leukaemia. Br J Haematol 1995; 91: 341–344
   PubMed Web of Science ®Google Scholar
• Eichhorst B F, Busch R, Hopfinger G, Pasold R, Hensel M, Steinbrecher C, , German CLL Study Group, et al. Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia. Blood 2006; 107: 885–891
   PubMed Web of Science ®Google Scholar
• Duhrsen U, Augener W, Zwingers T, Brittinger G. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. Br J Haematol 1987; 67: 235–239
   PubMed Web of Science ®Google Scholar
• Economopoulos T, Stathakis N, Constantinidou M, Papageorgiou E, Anastassiou C, Raptis S. Cold agglutinin disease in non-Hodgkin's lymphoma. Eur J Haematol 1995; 55: 69–71
   PubMed Web of Science ®Google Scholar
• Jones S E. Autoimmune disorders and malignant lymphoma. Cancer 1973; 31: 1092–1098
   PubMed Web of Science ®Google Scholar
• Gronbaek K, D'Amore F, Schmidt K. Autoimmune phenomena in non-Hodgkin's lymphoma. Leuk Lymphoma 1995; 18: 311–316
   PubMed Web of Science ®Google Scholar
• Varoczy L, Gergely L, Zeher M, Szegedi G, Illes A. Malignant lymphoma-associated autoimmune diseases—a descriptive epidemiological study. Rheumatol Int 2002; 22: 233–237
   PubMed Web of Science ®Google Scholar
• Garcia-Sanz R, Montoto S, Torrequebrada A, de Coca A G, Petit J, Sureda A, , Spanish Group for the Study of Waldenstrom Macroglobulinaemia and PETHEMA (Programme for the Study and Treatment of Haematological Malignancies), et al. Waldenstrom macroglobulinaemia: presenting features and outcome in a series with 217 cases. Br J Haematol 2001; 115: 575–582
   PubMed Web of Science ®Google Scholar
• Kyrtsonis M C, Vassilakopoulos T P, Angelopoulou M K, Siakantaris P, Kontopidou F N, Dimopoulou M N, et al. Waldenstrom's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit. Ann Hematol 2001; 80: 722–727
   PubMed Web of Science ®Google Scholar
• Dimopoulos M A, Panayiotidis P, Moulopoulos L A, Sfikakis P, Dalakas M. Waldenstrom's macroglobulinemia: clinical features, complications, and management. J Clin Oncol 2000; 18: 214–226
   PubMed Web of Science ®Google Scholar
• Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon P A, et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 2000; 95: 1950–1956
   PubMed Web of Science ®Google Scholar
• Coiffier B, Berger F, Bryon P A, Magaud J P. T-cell lymphomas: immunologic, histologic, clinical, and therapeutic analysis of 63 cases. J Clin Oncol 1988; 6: 1584–1589
   PubMed Web of Science ®Google Scholar
• Dogan A, Attygalle A D, Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol 2003; 121: 681–691
   PubMed Web of Science ®Google Scholar
• Pangalis G A, Moran E M, Rappaport H. Blood and bone marrow findings in angioimmunoblastic lymphadenopathy. Blood 1978; 51: 71–83
   PubMed Web of Science ®Google Scholar
• Pautier P, Devidas A, Delmer A, Dombret H, Sutton L, Zini J M, et al. Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma 1999; 32: 545–552
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Harris N L, Stein H, Vardiman J W. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, International Agency for Research on Cancer. 2001
   Google Scholar
• Boccardi V, Grasso A, Belsanti V. Autoimmune hemolytic anemia associated to the presence of an anti-i antibody in the course of Brill-Symmers disease. Haematol Lat 1968; 11: 151–158
   PubMedGoogle Scholar
• Cavanna L, Civardi G, Vallisa D, Berte R. Primary adrenal non-Hodgkin's lymphoma associated with autoimmune hemolytic anemia: a case diagnosed by ultrasound-guided fine needle biopsy. Ann Ital Med Int 1999; 14: 298–301
   PubMedGoogle Scholar
• Niitsu N, Nakayama M, Kato M, Umeda M. Non-Hodgkin's lymphoma associated with cold agglutinin disease. Rinsho Ketsueki 1997; 38: 587–592
   PubMedGoogle Scholar
• Nakashima Y, Abe Y, Ohtsuka R, Tachikawa Y, Nagasawa E, Nishimura J, et al. Follicular lymphoma complicated with autoimmune hemolytic anemia and pure red cell aplasia. Rinsho Ketsueki 2004; 45: 1208–1210
   PubMedGoogle Scholar
• Sallah S, Sigounas G, Vos P, Wan J Y, Nguyen N P. Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: characteristics and significance. Ann Oncol 2000; 11: 1571–1577
   PubMed Web of Science ®Google Scholar
• Suzuki K, Murata Y, Shiotani K, Kunikane M, Fukuda S, Yoshida Y, et al. Non-Hodgkin's lymphoma accompanied by autoimmune hemolytic anemia with anti-e autoantibody. Jpn J Med 1991; 30: 123–129
   PubMedGoogle Scholar
• Thieblemont C, Felman P, Callet-Bauchu E, Traverse-Glehen A, Salles G, Berger F, et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 2003; 4: 95–103
   PubMed Web of Science ®Google Scholar
• Bonichon N, Lifermann F, Fossats A, Canteloup B, Dauzan Y. Autoimmune hemolytic anemia disclosing splenic lymphoma with villous lymphocyte. Presse Med 1997; 26: 270
   PubMed Web of Science ®Google Scholar
• Gale R, Smith O P, Wood M, Mehta A B. Splenic lymphoma with villous lymphocytes complicated by autoimmune haemolytic anaemia. Lancet 1992; 340: 1106
   PubMed Web of Science ®Google Scholar
• Murakami H, Irisawa H, Saitoh T, Matsushima T, Tamura J, Sawamura M, et al. Immunological abnormalities in splenic marginal zone cell lymphoma. Am J Hematol 1997; 56: 173–178
   PubMed Web of Science ®Google Scholar
• Palomera L, Sola C, Arruga A, Domingo J M, Gutierrez M. Fatal autoimmune hemolytic anemia in a patient with splenic marginal-zone lymphoma with hairy lymphocytes. Rev Clin Esp 2002; 202: 360–361
   PubMed Web of Science ®Google Scholar
• Paydas S, Yavuz S, Disel U, Sahin B, Ergin M. Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase. Leuk Lymphoma 2003; 44: 2165–2166
   PubMed Web of Science ®Google Scholar
• Sawamura M, Yamaguchi S, Murakami H, Amagai H, Matsushima T, Tamura J, et al. Multiple autoantibody production in a patient with splenic lymphoma. Ann Hematol 1994; 68: 251–254
   PubMed Web of Science ®Google Scholar
• Yamazaki K. A case of splenic lymphoma with marked diffuse nodular fibrosis and calcification, complicated with severe autoimmune hemolytic anemia. J Submicrosc Cytol Pathol 2003; 35: 17–23
   PubMedGoogle Scholar
• Liaw Y S, Yang P C, Su I J, Kuo S H, Wang C H, Luh K T. Mucosa-associated lymphoid tissue lymphoma of the lung with cold-reacting autoantibody-mediated hemolytic anemia. Chest 1994; 105: 288–290
   PubMed Web of Science ®Google Scholar
• Petit J, Clavo M, de Sevilla A F, Gonzalez-Barca E, Domingo-Domenech E, Granena A. Refractory cold agglutinin-immunohaemolytic anaemia associated to marginal zone lymphoma responding to rituximab. Hematol J 2003; 4: 450–451
   PubMedGoogle Scholar
• Rivera Civico F, Omar M, Almagro M, Jimenez-Alonso J. Mucose-associated lymphoid tissue gastric lymphoma associated with Evans' syndrome. Med Clin (Barc) 1994; 102: 119
   PubMed Web of Science ®Google Scholar
• Mainwaring C J, Walewska R, Snowden J, Winfield D A, Ng J P, Chan-Lam D, et al. Fatal cold anti-i autoimmune haemolytic anaemia complicating hairy cell leukaemia. Br J Haematol 2000; 109: 641–643
   PubMed Web of Science ®Google Scholar
• Cesana C, Brando B, Boiani E, Chiodo F, Cairoli R, Intropido L, et al. Effective treatment of autoimmune hemolytic anemia and hairy cell leukemia with interferon-alpha. Eur J Haematol 2002; 68: 120–121
   PubMed Web of Science ®Google Scholar
• Guler N, Kansu E, Turker A, Barista I, Kanra T. Severe autoimmune hemolytic anemia in hairy cell leukemia. Eur J Haematol 1997; 58: 205–206
   PubMed Web of Science ®Google Scholar
• Moullet I, Salles G, Dumontet C, Bastion Y, Morel D, Felman P, et al. Severe immune thombocytopenic purpura and haemolytic anaemia in a hairy-cell leukaemia patient. Eur J Haematol 1995; 54: 127–129
   PubMed Web of Science ®Google Scholar
• Domingo A, Crespo N, Fernandez de Sevilla A, Domenech P, Jordan C, Callis M. Hairy cell leukemia and autoimmune hemolytic anemia. Leukemia 1992; 6: 606–607
   PubMed Web of Science ®Google Scholar
• Hofer S, Hunziker S, Dirnhofer S, Ludwig C. Rituximab effective in a patient with refractory autoimmune haemolytic anaemia and CD20-negative multiple myeloma. Br J Haematol 2003; 122: 690–691
   PubMed Web of Science ®Google Scholar
• Morado M, Canales M A, Aguado M J, Hernandez Navarro F. Association of multiple myeloma and autoimmune hemolytic anemia. Sangre (Barc) 1998; 43: 467–468
   PubMedGoogle Scholar
• Muroi K, Imagawa S, Suda T, Kajii E, Otuka Y, Sakurabayashi I, et al. Multiple myeloma with hemolytic anemia and thrombocytopenia. Rinsho Ketsueki 1991; 32: 909–911
   PubMedGoogle Scholar
• Nakase T, Morita K, Tomeoku M, Katou M, Kanamaru M, Shirakawa S. IgA-lambda type myeloma complicating with autoimmune hemolytic anemia. Rinsho Ketsueki 1990; 31: 1967–1968
   PubMedGoogle Scholar
• Onoda K, Takai K, Sanada M, Aoki S, Watanabe T. Autoimmune hemolytic anemia induced by alpha-interferon therapy in a case of IgG-kappa type multiple myeloma. Rinsho Ketsueki 1992; 33: 844–846
   PubMedGoogle Scholar
• Pengelly C D, Mondal B K, Barua A R. Haemolytic anaemia in myelomatosis. Postgrad Med J 1973; 49: 279–281
   PubMed Web of Science ®Google Scholar
• Pereira A, Mazzara R, Escoda L, Alcorta I, Nomdedeu B, Roelcke D. Anti-Sa cold agglutinin of IgA class requiring plasma-exchange therapy as early manifestation of multiple myeloma. Ann Hematol 1993; 66: 315–318
   PubMed Web of Science ®Google Scholar
• Yonekura S, Nagao T, Arimori S, Miyaji M, Ogoshi K, Tsutsumi Y. Evans' syndrome associated with gastric plasmacytoma: case report and a review of the literature. Jpn J Med 1990; 29: 512–515
   PubMedGoogle Scholar
• Vaiopoulos G, Kyriakou D, Papadaki H, Fessas P, Eliopoulos G D. Multiple myeloma associated with autoimmune hemolytic anemia. Haematologica 1994; 79: 262–264
   PubMed Web of Science ®Google Scholar
• Wada H, Yata K, Mikami M, Suemori S, Nakanishi H, Kondo T, et al. Multiple myeloma complicated by autoimmune hemolytic anemia. Intern Med 2004; 43: 595–598
   PubMed Web of Science ®Google Scholar
• Bar B M, Reijnders F J, Keuning J J, Bal H, van Beek M. Primary malignant lymphoma of the uterine cervix associated with cold-reacting autoantibody-mediated hemolytic anemia. Acta Haematol 1986; 75: 232–235
   PubMed Web of Science ®Google Scholar
• Chiba H, Matsunaga T, Kuribayashi K, Nikaido T, Shirao S, Murakami K, et al. Autoimmune hemolytic anemia as a first manifestation of primary effusion lymphoma. Ann Hematol 2003; 82: 773–776
   PubMed Web of Science ®Google Scholar
• Chng W J, Chen J, Lim S, Chong S M, Kueh Y K, Lee S H. Translocation (8;22) in cold agglutinin disease associated with B-cell lymphoma. Cancer Genet Cytogenet 2004; 152: 66–69
   PubMed Web of Science ®Google Scholar
• Hirose Y, Takeshita S, Shimizu S, Ogawa Y, Masaki Y, Fukutoku M, et al. Dissemination of Epstein-Barr virus associated B-cell lymphoma of the brain after development of immunological incompetence with Evans' syndrome. Int J Hematol 1998; 67: 81–86
   PubMed Web of Science ®Google Scholar
• Katayama H, Takeuchi M, Yoshino T, Munemasa M, Tada A, Soda R, et al. Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia. Leuk Lymphoma 2001; 42: 539–542
   PubMed Web of Science ®Google Scholar
• Kubota T, Daibata M, Kobayashi M, Taguchi H. Malignant lymphoma of the lung associated with Evans' syndrome: report of a case. Nihon Kokyuki Gakkai Zasshi 2002; 40: 965–969
   PubMedGoogle Scholar
• Kubota Y. A case of primary pulmonary malignant lymphoma associated with autoimmune hemolytic anemia. Nihon Kokyuki Gakkai Zasshi 2006; 44: 453–457
   PubMedGoogle Scholar
• Kuipers E J, van Imhoff G W, Hazenberg C A, Smit J. Anti-H IgM (kappa) autoantibody mediated severe intravascular haemolysis associated with malignant lymphoma. Br J Haematol 1991; 78: 283–285
   PubMed Web of Science ®Google Scholar
• Sivakumaran M, Murphy P T, Booker D J, Wood J K, Stamps R, Sokol R J. Paroxysmal cold haemoglobinuria caused by non-Hodgkin's lymphoma. Br J Haematol 1999; 105: 278–279
   PubMed Web of Science ®Google Scholar
• Kuroda H, Matsunaga T, Iyama S, Takimoto R, Shirao S, Kida M, et al. De novo CD5-positive diffuse large B-cell lymphoma associated with autoimmune hemolytic anemia presenting as erythroid hypoplasia. Rinsho Ketsueki 2006; 47: 633–638
   PubMedGoogle Scholar
• Roca-Tey R, Borrellas X, Cantarell C, Capdevila L, Piera L. Immunoblastic lymphoma of the colon in a renal transplant patient presenting with autoimmune haemolytic anaemia of the cold antibody type. Nephrol Dial Transplant 1997; 12: 2000–2001
   PubMed Web of Science ®Google Scholar
• Sonoki T, Matsuzaki H, Asou N, Hata H, Matsuno F, Yoshida M, et al. Aggressive CD5-positive diffuse large B cell lymphoma showing c-myc rearrangements developed in a patient with autoimmune hemolytic anemia. Int J Hematol 1996; 63: 71–76
   PubMed Web of Science ®Google Scholar
• Sandhaus L M, Raska K, Jr, Wu H V. Diffuse large-cell lymphoma with monoclonal IgM kappa and cold agglutinin. Am J Clin Pathol 1986; 86: 120–123
   PubMed Web of Science ®Google Scholar
• Takai K, Sanada M, Shibuya H. Anti-Pr2 cold agglutinin disease with polyneuropathy evolving to malignant lymphoma. Rinsho Ketsueki 1992; 33: 1231–1236
   PubMedGoogle Scholar
• Terpos E, Theocharis S, Panitsas F, Philippidis T, Kotronis E, Karkantaris C. Autoimmune hemolytic anemia with myelodysplastic features followed by bilateral adrenal non-hodgkin lymphoma: a case report and review of the literature. Leuk Lymphoma 2004; 45: 2333–2338
   PubMed Web of Science ®Google Scholar
• Zeidman A, Fradin Z, Barac Y, Bendayan D, Mittelman M, Orlin J. Splenic lymphoma presenting as warm autoimmune hemolytic anemia associated with pure red cell aplasia. Vox Sang 2000; 78: 126–129
   PubMed Web of Science ®Google Scholar
• Yoshimoto T, Araki Y, Kawano K, Kamata T, Okamoto S, Ogawa T. Primary hepatic lymphoma in a patient with autoimmune hemolytic anemia and SLE. Rinsho Ketsueki 1990; 31: 1878–1883
   PubMedGoogle Scholar
• Toyota S, Nakamura N, Dan K. Coexistence of pure red cell aplasia and autoimmune hemolytic anemia occurring during remission of malignant lymphoma. Rinsho Ketsueki 2002; 43: 493–495
   PubMedGoogle Scholar
• Trape G, Fianchi L, Lai M, Laurenti L, Piscitelli R, Leone G, et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders. Haematologica 2003; 88: 223–225
   PubMed Web of Science ®Google Scholar
• Alberti E, Aldovini D, Mazzon C, Dal Ri P, Rubertelli M. Angioimmunoblastic Lymphadenopathy with Dysproteinemia. Report of a case with pure red cell aplasia. Haematologica 1982; 67: 919–925
   PubMed Web of Science ®Google Scholar
• Al Hilali M, Joyner M V. Pure red-cell aplasia secondary to angioimmunoblastic lymphadenopathy. J R Soc Med 1983; 76: 894–895
   PubMed Web of Science ®Google Scholar
• Berenbaum F, Mariette X, Bisson M, Clerc D. Severe hemolytic anemia in angio-immunoblastic lymphadenopathy. Value of intravenous immunoglobulins. Ann Med Interne (Paris) 1990; 141: 197–198
   PubMedGoogle Scholar
• Ferrer S, Pla A, Monzo E, Baeza R, Martinez Escudero J, Sancho-Tello R, et al. Angioimmunoblastic lymphadenopathy with dysproteinemia and autoimmune hemolytic anemia. Apropos of a case. Rev Clin Esp 1980; 158: 145–149, 15 – 31
   PubMed Web of Science ®Google Scholar
• Lynch J W, Elfenbein G J, Noyes W D, Braylan R C, Gross M A, Weiner R S. Pure red cell aplasia associated with angioimmunoblastic lymphadenopathy with dysproteinemia. Am J Hematol 1994; 46: 72–78
   PubMed Web of Science ®Google Scholar
• Mairano D, Cargnino M, Rosso F, Marchi L, Biarese V, Lovisetto P. Autoimmune hemolytic onset of angioimmunoblastic lymphadenopathy with disproteinemia. Recenti Prog Med 1985; 76: 15–17
   PubMedGoogle Scholar
• Mannoji M, Shimoda M, Koresawa S, Yamada O, Togawa A, Yawata Y, et al. A case of angioimmunoblastic lymphadenopathy with dysproteinemia associated with autoimmune hemolytic anemia and pure red cell aplasia—with special references to its pathogenesis (author's transl). Rinsho Ketsueki 1981; 22: 1751–1758
   PubMedGoogle Scholar
• Mizobe T, Tsukada J, Higashi T, Iwashige A, Ota T, Kawano I, et al. Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia. Rinsho Ketsueki 2005; 46: 211–216
   PubMedGoogle Scholar
• Schauer P K, Straus D J, Bagley C M, Jr, Rudolph R H, McCracken J D, Huff J, et al. Angioimmunoblastic lymphadenopathy: clinical spectrum of disease. Cancer 1981; 48: 2493–2498
   PubMed Web of Science ®Google Scholar
• Suehiro S, Shiratsuchi M, Suehiro Y, Oshima K, Shiokawa S, Nishimura J. Angioimmunoblastic T cell lymphoma (AITL) with autoimmune thrombocytopenia. Rinsho Ketsueki 2002; 43: 841–845
   PubMedGoogle Scholar
• Shirakawa C, Enomoto H, Tanaka H, Yonekawa S, Irimajiri K, Horiuchi A. Immunoblastic lymphadenopathy-like T cell lymphoma associated with erythroid hypoplasia and thrombocytopenia. Rinsho Ketsueki 1996; 37: 701–706
   PubMedGoogle Scholar
• Vukelja S J, Krishnan J, Link C M, Salvado A J, Knight R D. Resolution of pure red cell aplasia and lymphoma: response to intravenous gammaglobulin and combination chemotherapy. Am J Hematol 1989; 32: 129–133
   PubMed Web of Science ®Google Scholar
• Higuchi T, Mori H, Niikura H, Omine M. Hypocomplementemia and hematological abnormalities in immunoblastic lymphadenopathy and immunoblastic lymphadenopathy-like T cell lymphoma. Acta Haematol 1996; 96: 68–72
   PubMed Web of Science ®Google Scholar
• Niitsu N, Shikoshi K, Umeda M, Shirai T. Lennert's lymphoma associated with the syndrome of inappropriate secretion of antidiuretic hormone and autoimmune hemolytic anemia. Rinsho Ketsueki 1994; 35: 80–84
   PubMedGoogle Scholar
• Osawa H, Otsuka T, Inoue T, Sumida I, Hanada M, Okamura T, et al. Immunoblastic lymphadenopathy (IBL)-like T cell lymphoma associated with granulocytopenia and autoimmune hemolytic anemia. Rinsho Ketsueki 1993; 34: 165–170
   PubMedGoogle Scholar
• Takayanagi N, Sampi K. Immunoblastic lymphadenopathy-like T cell lymphoma with high levels of serum interleukin-6, cold agglutinin disease, and immune thrombocytopenia. Rinsho Ketsueki 1998; 39: 1109–1114
   PubMedGoogle Scholar
• Tamura M, Iki S, Yagisawa M, Mitani K, Ohbayashi Y, Sato H, et al. Immunoblastic lymphadenopathy-like T cell lymphoma accompanied by autoimmune hemolytic anemia. Rinsho Ketsueki 1992; 33: 396–401
   PubMedGoogle Scholar
• Bachmeyer C, Blum L, Chesneau A M, Richecoeur J, Testard F, Benchaa B, et al. Raynaud's phenomenon with necrosis of the extremities induced by cold agglutinin disease secondary to a T-cell lymphoma. Acta Derm Venereol 2003; 83: 374–375
   PubMed Web of Science ®Google Scholar
• Sakai C, Fujiwara M, Takagi T, Oguro M, Maruyama K. Red cell hypoplasia following autoimmune hemolytic anemia associated with T-CLL: report of a case and review of the literature. Rinsho Ketsueki 1989; 30: 850–857
   PubMedGoogle Scholar
• Evers J, Albert F, Bazar L, Sulica V, Sacher R A. Autoimmune hemolytic anemia presenting in Sezary syndrome. Report of a case and review of the literature. Acta Haematol 1992; 88: 46–49
   PubMed Web of Science ®Google Scholar
• Michallet A S, Lesca G, Radford-Weiss I, Delarue R, Varet B, Buzyn A. T-cell prolymphocytic leukemia with autoimmune manifestations in Nijmegen breakage syndrome. Ann Hematol 2003; 82: 515–517
   PubMed Web of Science ®Google Scholar
• de Misa R F, Megido M. Autoimmune hemolytic anemia and cutaneous T cell lymphoma: review of the literature. Acta Haematol 1993; 89: 168
   PubMed Web of Science ®Google Scholar
• Pouderoux P, Gris J C, Pignodel C, Joujoux J M, Schved J F, Balmes J L. Primary sinusoidal lymphoma of the liver revealed by autoimmune hemolytic anemia. Gastroenterol Clin Biol 1997; 21: 514–518
   PubMed Web of Science ®Google Scholar
• Lai R, Larratt L M, Etches W, Mortimer S T, Jewell L D, Dabbagh L, et al. Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia. Am J Surg Pathol 2000; 24: 459–463
   PubMed Web of Science ®Google Scholar
• Minauchi K, Nishio M, Itoh T, Yamamoto S, Fujimoto K, Sato N, et al. Hepatosplenic alpha/beta T cell lymphoma presenting with cold agglutinin disease. Ann Hematol 2007; 86: 155–157
   PubMed Web of Science ®Google Scholar
• Loughran T P, Jr, Starkebaum G. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine (Baltimore) 1987; 66: 397–405
   PubMed Web of Science ®Google Scholar
• Kawachi Y, Ide M, Uchida T, Setsu K. Idiopathic thrombocytopenic purpura associated with mantle cell lymphoma showing an increase in the platelet count receiving anti-CD20 antibody rituximab. Rinsho Ketsueki 2003; 44: 31–33
   PubMedGoogle Scholar
• Serrano J. Autoimmune hemolytic anemia. Review of 200 cases studied in a period of 20 years (1970 – 1989). Sangre (Barc) 1992; 37: 265–274
   PubMedGoogle Scholar
• Borthakur G, O'Brien S, Wierda W G, Thomas D A, Cortes J E, Kantarjian H, et al. Immune anemias in patients with chronic lymphocytic leukaemia treated with Fludarabine, cyclophosphamide and rituximab. ASCO 2006, abstr. 6604
   Google Scholar
• Oshimi K, Yamada O, Kaneko T, Nishinarita S, Iizuka Y, Urabe A, et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993; 7: 782–788
   PubMed Web of Science ®Google Scholar
• Genty I, Michel M, Hermine O, Schaeffer A, Godeau B, Rochant H. Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases. Rev Med Interne 2002; 23: 901–909
   PubMed Web of Science ®Google Scholar
• Jardin F, Levesque H, Tilly H. Auto-immune manifestations in non-Hodgkin's lymphoma. Rev Med Interne 2005; 26: 557–571
   PubMed Web of Science ®Google Scholar
• Jonsson V, Kierkegaard A, Salling S, Molander S, Andersen L P, Christiansen M, et al. Autoimmunity in Waldenstrom's macroglobulinaemia. Leuk Lymphoma 1999; 34: 373–379
   PubMed Web of Science ®Google Scholar
• Smedby K E, Hjalgrim H, Askling J, Chang E T, Gregersen H, Porwit-MacDonald A, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006; 98: 51–60
   PubMed Web of Science ®Google Scholar
• Nobuoka A, Sakamaki S, Kogawa K, Fujikawa K, Takahashi M, Hirayama Y, et al. A case of malignant lymphoma producing autoantibody against platelet glycoprotein Ib. Int J Hematol 1999; 70: 200–206
   PubMed Web of Science ®Google Scholar
• Baudard M, Pagnoux C, Audouin J, Buy J N, Bethoux J P, Delmer A, et al. Idiopathic thrombocytopenic purpura as the presenting feature of a primary bilateral adrenal non Hodgkin's lymphoma. Leuk Lymphoma 1997; 26: 609–613
   PubMed Web of Science ®Google Scholar
• Aghai E, Quitt M, Lurie M, Antal S, Cohen L, Bitterman H, et al. Primary hepatic lymphoma presenting as symptomatic immune thrombocytopenic purpura. Cancer 1987; 60: 2308–2311
   PubMed Web of Science ®Google Scholar
• Kawashima T, Nishimura H, Akiyama H, Hirai K, Yamagishi S, Okada D, et al. Primary pulmonary mucosa-associated lymphoid tissue lymphoma combined with idiopathic thrombocytopenic purpura and amyloidoma in the lung. J Nippon Med Sch 2005; 72: 370–374
   PubMedGoogle Scholar
• Noda M, Mori N, Nomura K, Kojima K, Mitsufuji S, Yamane I, et al. Regression of idiopathic thrombocytopenic purpura after endoscopic mucosal resection of gastric mucosa associated lymphoid tissue lymphoma. Gut 2004; 53: 1698–1700
   PubMed Web of Science ®Google Scholar
• Catovsky D, Richards S, Hillman P. Early results from LRF CLL4. A UK multicenter randomized trial. Blood 2005; 106: 212a, (abstract)
   Web of Science ®Google Scholar
• Leporrier M, Chevret S, Cazin B, Boudjerra N, Feugier P, Desablens B, et al. French Cooperative Group on Chronic Lymphocytic Leukemia. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood 2001; 98: 2319–2325
   PubMed Web of Science ®Google Scholar
• Johnson S, Smith A G, Loffler H, Osby E, Juliusson G, Emmerich B, et al. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL. Lancet 1996; 347: 1432–1438
   PubMed Web of Science ®Google Scholar
• Robak T, Blonski J Z, Gora-Tybor J, Jamroziak K, Dwilewicz-Trojaczek J, Tomaszewska A, et al. Polish Leukemia Group (PALG CLL2). Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2). Blood 2006; 108: 473–479
   PubMed Web of Science ®Google Scholar
• Tobinai K, Watanabe T, Ogura M, Morishima Y, Ogawa Y, Ishizawa K, et al. Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma. J Clin Oncol 2006; 24: 174–180
   PubMed Web of Science ®Google Scholar
• Tsatalas C, Margaritis D, Kaloutsi V, Martinis G, Kotsianidis I, Bourikas G. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine. Acta Haematol 2001; 105: 106–108
   PubMed Web of Science ®Google Scholar
• Morris G J, Millenson M M, Padavic-Shaller K, Wang H, Rogatko A, Clyde J, et al. Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma. Haematologica 2004; 89: 1484–1491
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Magagnoli M, Moretti L, De Renzo A, Battista R, Zaccaria A, et al. Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma. J Clin Oncol 2000; 18: 773–779
   PubMed Web of Science ®Google Scholar
• Lenz G, Hiddemann W, Dreyling M. The role of fludarabine in the treatment of follicular and mantle cell lymphoma. Cancer 2004; 101: 883–893
   PubMed Web of Science ®Google Scholar
• Foran J M, Rohatiner A Z, Coiffier B, Barbui T, Johnson S A, Hiddemann W, et al. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma. J Clin Oncol 1999; 17: 546–553
   PubMed Web of Science ®Google Scholar
• Flinn I W, Byrd J C, Morrison C, Jamison J, Diehl L F, Murphy T, et al. Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies. Blood 2000; 96: 71–75
   PubMed Web of Science ®Google Scholar
• Hochster H S, Oken M M, Winter J N, Gordon L I, Raphael B G, Bennett J M, et al. Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up—a report from the Eastern Cooperative Oncology Group. J Clin Oncol 2000; 18: 987–994
   PubMed Web of Science ®Google Scholar
• Solal-Celigny P, Brice P, Brousse N, Caspard H, Bastion Y, Haioun C, et al. Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1996; 14: 514–519
   PubMed Web of Science ®Google Scholar
• McLaughlin P, Hagemeister F B, Romaguera J E, Sarris A H, Pate O, Younes A, et al. Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. J Clin Oncol 1996; 14: 1262–1268
   PubMed Web of Science ®Google Scholar
• Betticher D C, von Rohr A, Ratschiller D, Schmitz S F, Egger T, Sonderegger T, et al. Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma. J Clin Oncol 1998; 16: 850–858
   PubMed Web of Science ®Google Scholar
• Kay A C, Saven A, Carrera C J, Carson D A, Thurston D, Beutler E, et al. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas. J Clin Oncol 1992; 10: 371–377
   PubMed Web of Science ®Google Scholar
• Aslan D L, Peterson B A, Long-Tsai M, Eastlund T. Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenstrom's macroglobulinemia. Transfusion 2006; 46: 90–94
   PubMed Web of Science ®Google Scholar
• Tetreault S A, Saven A. Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenstrom macroglobulinemia. Leuk Lymphoma 2000; 37: 125–130
   PubMed Web of Science ®Google Scholar
• Jourdan E, Topart D, Richard B, Jourdan J, Sotto A. Severe autoimmune haemolytic anaemia following rituximab therapy in a patient with lymphoproliferative disorder. Leuk Lymphoma 2003; 44: 889–890
   PubMed Web of Science ®Google Scholar
• Bauduer F. Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-pos, low-grade non-Hodgkin's lymphoma. Br J Haematol 2001; 112: 1085
   PubMed Web of Science ®Google Scholar
• Stevenson F K, Spellerberg M B, Chapman C J, Hamblin T J. Differential usage of an autoantibody-associated VH-gene, VH4-21, by human B-cell tumors. Leuk Lymphoma 1995; 16: 379–384
   PubMed Web of Science ®Google Scholar